StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.06 (-22.78%)

Close on Nov 16, 2026Market cap $29.43MP/E –Yield –

Xtant Medical cash

Cash and short-term investments held at the end of each period.

Xtant Medical's cash was $9.87M at Jun 30, 2026. For fiscal 2025 it was $17.05M, up 175.1% from the year before. Over ten years it grew 10.4% a year on average. The highest annual figure on record is $20.30M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.05M+175.1%
FY2024Dec 31, 2024$6.20M+8.5%
FY2023Dec 31, 2023$5.72M-71.8%
FY2022Dec 31, 2022$20.30M+11.3%
FY2021Dec 31, 2021$18.24M+679.3%
FY2020Dec 31, 2020$2.34M-55.3%
FY2019Dec 31, 2019$5.24M-23.0%
FY2018Dec 31, 2018$6.80M+138.0%
FY2017Dec 31, 2017$2.86M+10.8%
FY2016Dec 31, 2016$2.58M-59.5%
FY2015Dec 31, 2015$6.37M+42.5%
FY2014Dec 31, 2014$4.47M+46.7%
FY2013Dec 31, 2013$3.05M-38.2%
FY2012Dec 31, 2012$4.93M+555.8%
FY2011Dec 31, 2011$751.11K+129.4%
FY2010Dec 31, 2010$327.48K+504.7%
FY2009Dec 31, 2009$54.16K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.87M+42.6%
Q1 FY2026Mar 31, 2026$12.14M+141.2%
Q4 FY2025Dec 31, 2025$17.05M+175.1%
Q3 FY2025Sep 30, 2025$10.40M+57.7%
Q2 FY2025Jun 30, 2025$6.92M+28.7%
Q1 FY2025Mar 31, 2025$5.03M+10.7%
Q4 FY2024Dec 31, 2024$6.20M+8.5%
Q3 FY2024Sep 30, 2024$6.60M-23.9%
Q2 FY2024Jun 30, 2024$5.38M+30.0%
Q1 FY2024Mar 31, 2024$4.55M-12.2%
Q4 FY2023Dec 31, 2023$5.72M-71.8%
Q3 FY2023Sep 30, 2023$8.66M-50.1%
Q2 FY2023Jun 30, 2023$4.14M-74.9%
Q1 FY2023Mar 31, 2023$5.18M-69.3%
Q4 FY2022Dec 31, 2022$20.30M+11.3%
Q3 FY2022Sep 30, 2022$17.36M-4.5%
Q2 FY2022Jun 30, 2022$16.50M-18.8%
Q1 FY2022Mar 31, 2022$16.85M-9.6%
Q4 FY2021Dec 31, 2021$18.24M+679.3%
Q3 FY2021Sep 30, 2021$18.18M+563.1%
Q2 FY2021Jun 30, 2021$20.31M+572.8%
Q1 FY2021Mar 31, 2021$18.64M+475.6%
Q4 FY2020Dec 31, 2020$2.34M-55.3%
Q3 FY2020Sep 30, 2020$2.74M-52.3%
Q2 FY2020Jun 30, 2020$3.02M-58.7%
Q1 FY2020Mar 31, 2020$3.24M-54.4%
Q4 FY2019Dec 31, 2019$5.24M-23.0%
Q3 FY2019Sep 30, 2019$5.75M+13.5%
Q2 FY2019Jun 30, 2019$7.32M+21.0%
Q1 FY2019Mar 31, 2019$7.10M+15.0%
Q4 FY2018Dec 31, 2018$6.80M+138.0%
Q3 FY2018Sep 30, 2018$5.06M+144.8%
Q2 FY2018Jun 30, 2018$6.05M+263.3%
Q1 FY2018Mar 31, 2018$6.17M+148.2%
Q4 FY2017Dec 31, 2017$2.86M+10.8%
Q3 FY2017Sep 30, 2017$2.07M+46.9%
Q2 FY2017Jun 30, 2017$1.67M–
Q1 FY2017Mar 31, 2017$2.49M–
Q4 FY2016Dec 31, 2016$2.58M–
Q3 FY2016Sep 30, 2016$1.41M–

More Xtant Medical figures

See a number that looks wrong?